AIFF
Firefly Neuroscience, Inc. NASDAQ Listed Nov 28, 2002$1.36
Pre-mkt
$1.35
-0.74%
Mkt Cap $20.1M
52w Low $0.62
29.3% of range
52w High $3.15
50d MA $1.17
200d MA $1.37
P/E (TTM)
—
EV/EBITDA
—
P/B
2.4x
Debt/Equity
0.0x
ROE
-260.3%
P/FCF
-2.2x
RSI (14)
57.30
ATR (14)
$0.18
Beta
0.58
50d MA
$1.17
200d MA
$1.37
Avg Volume
5.5M
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
150 King St W · Kenmore, ON M5H 1J9 · CA
Data updated apr 24, 2026 4:47pm
· Source: financialmodelingprep.com